Navigation Links
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Date:5/10/2013

tion, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersCindy McGee, Vice President,

David Schull, PresidentInvestor Relations & Alliance Management

david.schull@russopartnersllc.comcmcgee@arenapharm.com

858.717.2310858.453.7200, ext. 1479
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
2. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
3. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
4. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
5. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
6. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
7. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
9. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
10. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
11. Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... BRIDGEWATER, N.J., Sept. 17 Ortho Biotech has ... study,of the effects of Epoetin alfa in patients ... acute ischemic stroke who were treated with,Epoetin alfa ... symptoms died more,frequently than patients receiving placebo. Ortho ...
... 17 Sanofi pasteur, the,vaccines division of the ... Phase II clinical study exploring a multi-pronged treatment,approach ... often fatal form of,cancer for which there are ... United States and Canada. The trial, called MEL11, ...
Cached Medicine Technology:Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
(Date:3/2/2015)... 2015 Secura Consultants announced today ... First Protective Insurance Group of Birmingham, AL (First ... Protective affiliated advisors to access the enhanced disability ... Consultants delivers. , Secura Consultants, based ... the design and implementation of insured income protection ...
(Date:3/1/2015)... March 02, 2015 As residents ... works co-founders, Michael Burns and Carita Weaver, believe ... to working with the Southlake Chamber of Commerce, ... web works recently launched a website for Southlake ... A primary communications tool for Hill’s campaign, the ...
(Date:3/1/2015)... March 01, 2015 Comparing a new ... when using the Quotes Pros portal this year. A ... auto insurance rates that are being supplied through the ... updated agencies and prices available for each policy is ... online. Every system user will first be asked to ...
(Date:3/1/2015)... 2015 A federal court overseeing ... scheduled to go to trial in October has ... to provide testimony regarding the role an Italian ... Profemur device, Bernstein Liebhard LLP comments. According to ... District of Iowa on February 25th, Wright Medical ...
(Date:3/1/2015)... 01, 2015 Indiana Fiber Network, ... Provider, announces NewWays Networking, LLC (NewWays) selected IFN ... with IFN, NewWays is well positioned to scale ... for Internet bandwidth in rural parts of Indiana,” ... to Cory Childs IFN Enterprise Sales Manager, IFN ...
Breaking Medicine News(10 mins):Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2
... out of the skin without pricking it makes for easier ... which uses the application of an electric field// to draw ... need for an injection. It could mean taking blood samples ... ,Researchers at the University of Texas, tried to ...
... become a reality some day, according to researchers who have ... strength and endurance. ,With this basic knowledge in ... that pumps up muscle cells without all that exercise, said ... School of Medicine. The main target of the study is ...
... from the plants Camellia sinensis contains polyphenols in the ... gives the tea its antioxidant properties. Polyphenols protect the ... , Oxidation produces ... in the body and an increased amount of them ...
... which they say has proved 100% precise in early ... brain,// and has been devised to learn from experience ... the University of British Columbia, by Peter Liddle, a ... the brain scan of patients looking for certain characteristics ...
... psychiatrist has discovered that treating patients with oestrogen can ... drugs like risperidone have been shown to help many ... suspected for some time that oestrogen can help protect ... the disease than men and it usually strikes them ...
... began two days of public hearings to decide whether ... a doctor's prescription. A number of medications are being ... pills. But there are inconsistent views about how this ... ,Prescription drug usage has risen in recent years, due, ...
Cached Medicine News:
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: